Heterogeneity of epithelial and stromal cells of head and neck squamous cell carcinomas in ex vivo chemoresponse

[1]  A. Dietz,et al.  Single Tissue Samples from Head and Neck Squamous Cell Carcinomas are Representative Regarding the Entire Tumor’s Chemosensitivity to Cisplatin and Docetaxel , 2009, Oncology Research and Treatment.

[2]  J. Werner,et al.  Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial) , 2009, European Archives of Oto-Rhino-Laryngology.

[3]  T. Whiteside,et al.  Alterations in the p53 pathway and their association with radio- and chemosensitivity in head and neck squamous cell carcinoma. , 2008, Oral oncology.

[4]  T. Ogawa,et al.  Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer. , 2007, Oral oncology.

[5]  D. Guernsey,et al.  Stem cells, senescence, neosis and self-renewal in cancer , 2006, Cancer Cell International.

[6]  I. Witz,et al.  The tumor microenvironment in the post-PAGET era. , 2006, Cancer letters.

[7]  A. Dietz,et al.  Ex vivo chemosensitivity of head and neck carcinoma to cytostatic drug combinations. , 2006, Anticancer research.

[8]  E. Rosenthal,et al.  Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo , 2006, BMC Cancer.

[9]  D. Guernsey,et al.  Neosis—a paradigm of self‐renewal in cancer , 2005, Cell biology international.

[10]  M. Heuser,et al.  Cytotoxicity determination without photochemical artifacts. , 2005, Cancer letters.

[11]  J. Grandis,et al.  Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl‐2 expression and increased susceptibility to cisplatin‐induced apoptosis , 2004, Head & neck.

[12]  E. Rosenthal,et al.  Expression of proteolytic enzymes in head and neck cancer-associated fibroblasts. , 2004, Archives of otolaryngology--head & neck surgery.

[13]  J. Werner,et al.  Is There a Role for Chemosensitivity Tests in Head and Neck Cancer? , 2004, Oncology Research and Treatment.

[14]  A. Dietz,et al.  The impact of stromal cell contamination on chemosensitivity testing of head and neck carcinoma. , 2004, Anticancer research.

[15]  S. Temam,et al.  Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck , 2002, British Journal of Cancer.

[16]  J. Shah,et al.  Prediction of survival in patients with head and neck cancer using the histoculture drug response assay , 2002, Head & neck.

[17]  G. Miller,et al.  The effect of fibroblast growth factor 8, isoform b, on the biology of prostate carcinoma cells and their interaction with stromal cells. , 2000, Cancer research.

[18]  P. Beaune,et al.  p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  P. Dumont,et al.  Evaluation of a prediction model of cisplatin dose based on total platinum plasma concentration. , 1996, European journal of cancer.

[20]  C. Granzow,et al.  Riboflavin-mediated photosensitization of Vinca alkaloids distorts drug sensitivity assays. , 1995, Cancer research.

[21]  D. Kerr,et al.  Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion. , 1993, Cancer research.

[22]  Masahiko Watanabe,et al.  High in vitro‐in vivo correlation of drug response using sponge‐gel‐supported three‐dimensional histoculture and the MTT end point , 1992, International journal of cancer.

[23]  H. Mukaida,et al.  Significance of freshly cultured fibroblasts from different tissues in promoting cancer cell growth , 1991, International journal of cancer.

[24]  R. Hoffman,et al.  Drug response of head and neck tumors in native-state histoculture. , 1991, Archives of otolaryngology--head & neck surgery.

[25]  J. Robb,et al.  The distinction of small cell and non-small cell lung cancer by growth in native-state histoculture. , 1990, Cancer research.

[26]  D. D. Hoff,et al.  He's not going to talk about in vitro predictive assays again, is he? , 1990, Journal of the National Cancer Institute.

[27]  D. V. Von Hoff.  He's not going to talk about in vitro predictive assays again, is he? , 1990, Journal of the National Cancer Institute.

[28]  C. Redfern,et al.  In vivo-like drug responses of human tumors growing in three-dimensional gel-supported primary culture. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Hoffman,et al.  In vivo-like growth of human tumors in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  L. Weisenthal,et al.  Clonogenic and nonclonogenic in vitro chemosensitivity assays. , 1985, Cancer treatment reports.

[31]  V. Courtenay,et al.  An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents. , 1978, British Journal of Cancer.

[32]  J. DiPaolo,et al.  Evaluation of inhibition of human tumor tissue by cancer chemotherapeutic drugs with an in vitro test. , 1961, Journal of the National Cancer Institute.

[33]  S. Gumport,et al.  Investigation of the relation between clinical and tissue-culture response to chemotherapeutic agents on human cancer. , 1957, The New England journal of medicine.